About Stab Vida
Stab Vida is a company based in Costa Da Caparica (Portugal) founded in 2001. Stab Vida offers products and services including Sanger Sequencing, Next Generation Sequencing, Fragment Analysis, Paternity Testing, and Oligonucleotides and Polymerases. Stab Vida operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
- Headquarter Costa Da Caparica, Portugal
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Stab Vida, Lda.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$279.17 K (USD), Grant
Oct 01, 2020
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stab Vida
Stab Vida offers a comprehensive portfolio of products and services, including Sanger Sequencing, Next Generation Sequencing, Fragment Analysis, Paternity Testing, and Oligonucleotides and Polymerases.
DNA sequencing service for research and diagnostic applications.
High-throughput sequencing for large-scale genetic studies.
Analysis of DNA fragments for molecular biology applications.
Genetic testing to determine biological relationships.
Products for PCR and genetic research purposes.
Funding Insights of Stab Vida
Investors in Stab Vida
Stab Vida has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Stab Vida
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stab Vida
Investment portfolio details for Stab Vida
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Stab Vida
Detailed financials for Stab Vida
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stab Vida Comparisons
Peer comparison for Stab Vida
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stab Vida
Stab Vida operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of Stab Vida
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stab Vida
Complete news archive for Stab Vida
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stab Vida
Stab Vida was founded in 2001 and raised its 1st funding round 13 years after it was founded.
Stab Vida is headquartered in Costa Da Caparica, Portugal. It is registered at Costa Da Caparica, Setubal, Portugal.
Stab Vida was founded in 2001 as a provider of research services within the molecular biology and genomics sector. Operations focus on delivering Sanger sequencing, next-generation sequencing, and fragment analysis through multiple technology platforms to academic and industrial clients. Clinical genomics and genetic testing are conducted for human and animal applications. Custom oligonucleotides, polymerases, antibodies, and ELISA assays are manufactured and distributed accordingly.
Stab Vida's top competitors include Novogene Corporation, BGI and Source BioScience.
Stab Vida offers Sanger Sequencing, Next Generation Sequencing, Fragment Analysis, Paternity Testing, and Oligonucleotides and Polymerases.
Stab Vida has 2 investors. Key investors include European Union, and EIC Fund.